{
 "PrintNo":"S3906","Session":2019,"Chamber":"SENATE","BillType":"Senate","Published":"2019-02-21T09:23:02.683921Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2020-01-08","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2019-02-21","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-08","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":377,"Name":"Gustavo Rivera","Short":"RIVERA"}],
 "Title":"Classifies gabapentin as a controlled substance","Summary":"Classifies gabapentin as a controlled substance.",
 "LawSection":"Public Health Law","LawCode":"Amd §§3371 & 3343-a, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to classifying gabapentin as a controlled substance",
 "PreviousVersions":["A10321-2017","S8145-2017"]
}